
The following adverse reactions have been reported spontaneously during post-marketing use. A precise frequency can not be estimated from available data (not known).
Gastrointestinal disorders: Gastro-intestinal disturbances have been observed, e.g. abdominal pain, diarrhea, nausea, vomiting, and dysphagia. Oesophageal lesion may occur when not applied as advised (see Dosage & Administration).
Skin and subcutaneous tissue disorders: Cutaneous effects have been observed, e.g. rash, pruritus, urticaria, and erythema.
Immune system disorders: Hypersensitivity.